rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Peter M. Castleman

Director

Company insider

Files Form 4 as: Director, Caris Life Sciences; Director, Herbalife; 10% owner, RBC Bearings.

In numbers

Trades disclosed
15
Buys
0
Sells
1
Bought
$0
Sold
$109.8M
Companies
3
Companies where not an officer
3
First trade
12 Apr 2006
Last trade
14 Aug 2026
Last filed
14 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CAI Caris Life SciencesDirector · Diagnostics & Labs · last 14 Aug 20260 buys · 0 sells
HLF HerbalifeDirector · Health Care Distribution · last 3 May 20070 buys · 0 sells
RBC RBC Bearings10% owner · Machinery · last 12 Apr 20060 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Aug 2026filed 14 Aug 2026CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code A—13,192 at $0.00filing
14 Aug 2026filed 14 Aug 2026CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code A—13,192 at $0.00filing
26 Feb 2026filed 27 Feb 2026CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code A$111K5,509 at $20.06filing
26 Feb 2026filed 27 Feb 2026CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code A$111K5,509 at $20.06filing
9 Jan 2026filed 13 Jan 2026CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code M$47K2,500 at $18.60filing
9 Jan 2026filed 13 Jan 2026CAI Caris Life Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,500 at $0.00filing
9 Jan 2026filed 13 Jan 2026CAI Caris Life Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—2,500 at $0.00filing
9 Jan 2026filed 13 Jan 2026CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code M$47K2,500 at $18.60filing
20 Jun 2025filed 23 Jun 2025CAI Caris Life Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—40,983,607filing
20 Jun 2025filed 23 Jun 2025CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code C—10,245,906 at $0.00filing
27 Feb 2025filed 23 Jun 2025CAI Caris Life Sciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—2,500 at $0.00filing
27 Feb 2025filed 23 Jun 2025CAI Caris Life SciencesDiagnostics & LabsSEC FORM 4 Code A—16,129 at $0.00filing
3 May 2007filed 4 May 2007HLF HerbalifeHealth Care DistributionSEC FORM 4 Code J—17,548,096 at $0.00filing
3 May 2007filed 4 May 2007HLF HerbalifeHealth Care DistributionSEC FORM 4 Code J—146,142 at $0.00filing
12 Apr 2006filed 13 Apr 2006RBC RBC BearingsMachinerySEC FORM 4 Sold$109.8M5,637,412 at $19.48filing

News

RBC Bearings Incorporated (NYSE:RBC) Stock Has Average Price Target of $615.44RBC · dailypolitical.com · 6 Oct 2026

0 headlines in the last 90 days name Peter M. Castleman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Industrials1

Buys in green, sells in red, by the company’s sector.

Related people

John Russel DentonOfficer · Officer at Caris Life Sciences, filing Form 4 there in the last year
Brian J. BrilleDirector and Officer · Director and Officer at Caris Life Sciences, filing Form 4 there in the last year
David Baxley SpetzlerPresident · President at Caris Life Sciences, filing Form 4 there in the last year
Laura I. JohansenDirector · Director at Caris Life Sciences, filing Form 4 there in the last year
T. Danny PhillipsDirector · Director at Caris Life Sciences, filing Form 4 there in the last year
Gilbert Ray Cisneros, Jr.Representative, CA-31 · Also traded RBC in the last 90 days